1. Home
  2. LARK vs MXCT Comparison

LARK vs MXCT Comparison

Compare LARK & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

SELL

Current Price

$32.30

Market Cap

190.1M

Sector

Finance

ML Signal

SELL

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.19

Market Cap

155.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LARK
MXCT
Founded
1885
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
155.8M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
LARK
MXCT
Price
$32.30
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.11
AVG Volume (30 Days)
4.6K
★ 1.9M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
★ 2.60%
N/A
EPS Growth
★ 35.84
N/A
EPS
★ 2.59
N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$10.06
P/E Ratio
$12.48
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$23.57
$0.64
52 Week High
$34.60
$1.81

Technical Indicators

Market Signals
Indicator
LARK
MXCT
Relative Strength Index (RSI) 54.47 43.69
Support Level $30.92 $1.07
Resistance Level $32.40 $1.27
Average True Range (ATR) 0.43 0.17
MACD 0.02 -0.05
Stochastic Oscillator 53.56 24.32

Price Performance

Historical Comparison
LARK
MXCT

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: